ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,389, issued on Jan. 27, was assigned to THE TRUSTEES OF PRINCETON UNIVERSITY (Princeton, N.J.) and EMORY UNIVERSITY (Atlanta).
"Glycopeptide antibiotic combination therapy" was invented by Mohammad R. Seyedsayamdost (Princeton, N.J.), Vasiliki T. Chioti (Plainsboro, N.J.), Katherine M. Davis (Decatur, Ga.) and Kirklin L. McWhorter (Decatur, Ga.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Bacterial infections evading the current antibiotic arsenal warrant new treatment options. The mainstay treatment for Clostridium difficile infections involves administration of the broad-spectrum antibiotic vancomycin, which also depletes the gut microbiome and ...